<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The predisposition to <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> in <z:mp ids='MP_0002055'>diabetes</z:mp> may in part be related to the effects of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> or other metabolic abnormality on polymorphonuclear leukocytes (PMN) </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated oxidative respiratory burst activity (<z:chebi fb="1" ids="18421">superoxide</z:chebi> production) in non-stimulated and stimulated PMN from 70 stable type 2 Hispanic diabetic patients, as compared to 70 healthy Hispanic individuals without <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The influences of protein kinase C (PKC) inhibitors and certain antibiotics on <z:chebi fb="1" ids="18421">superoxide</z:chebi> production were examined </plain></SENT>
<SENT sid="3" pm="."><plain>Both resting and stimulated (<z:chebi fb="1" ids="53780">PMA</z:chebi>, zymosan) PMN from diabetic individuals produced more <z:chebi fb="1" ids="18421">superoxide</z:chebi> than PMN from controls </plain></SENT>
<SENT sid="4" pm="."><plain>Inhibitors of PKC, a possible mediator of the augmented respiratory burst activity, decreased <z:chebi fb="1" ids="18421">superoxide</z:chebi> production in <z:hpo ids='HP_0000001'>all</z:hpo> (resting and stimulated) diabetic and control PMN </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="2955">Azithromycin</z:chebi>, which is markedly concentrated by PMN, profoundly inhibited <z:chebi fb="1" ids="18421">superoxide</z:chebi> generation in <z:hpo ids='HP_0000001'>all</z:hpo> groups of diabetic and control cells </plain></SENT>
<SENT sid="6" pm="."><plain>PMN from Hispanic diabetic patients produced greater quantities of <z:chebi fb="1" ids="18421">superoxide</z:chebi> than non-diabetic controls </plain></SENT>
<SENT sid="7" pm="."><plain>This increased oxidative respiratory burst activity may predispose to <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> in <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>PKC inhibitors and <z:chebi fb="0" ids="2955">azithromycin</z:chebi> inhibited this respiratory burst response </plain></SENT>
<SENT sid="9" pm="."><plain>The possible role of PKC (especially PKC beta) as the mediator of this augmented respiratory burst response requires further evaluation, and may lead to therapeutic studies with appropriate inhibitors </plain></SENT>
</text></document>